Two novel antithetical KN blood group antigens may contribute to more than a quarter of all KN antisera in Europe.


Journal

Transfusion
ISSN: 1537-2995
Titre abrégé: Transfusion
Pays: United States
ID NLM: 0417360

Informations de publication

Date de publication:
10 2020
Historique:
received: 06 03 2020
revised: 09 07 2020
accepted: 17 07 2020
pubmed: 2 9 2020
medline: 30 6 2021
entrez: 2 9 2020
Statut: ppublish

Résumé

All antigens described in the KN blood group system are located in the long homologous repeat D (LHR-D) of complement receptor 1 (CR1). While there have been reports that some sera react only with the long homologous repeat C (LHR-C), the antigens in LHR-C are unknown. Recombinant LHR-C and LHR-D were used to identify antibodies directed against LHR-C of CR1, into which a point mutation was introduced to characterize the underlying blood group antigens. In addition, database studies to define haplotypes of CR1 were performed. Several antisera were identified that were specific against CR1 p.1208His and against CR1 p.1208Arg, located in LHR-C. Fifteen KN haplotypes were found in the Ensembl genome browser. It was shown that due to a linkage disequilibrium anti-CR1 p.1208His may be mistaken for anti-KCAM. A novel antithetical KN blood group antigen pair was found at position p.1208 of CR1, for which the names DACY and YCAD are proposed. Antibodies against these two novel antigens seem to contribute to more than a quarter of all KN sera in Europe.

Sections du résumé

BACKGROUND
All antigens described in the KN blood group system are located in the long homologous repeat D (LHR-D) of complement receptor 1 (CR1). While there have been reports that some sera react only with the long homologous repeat C (LHR-C), the antigens in LHR-C are unknown.
STUDY DESIGN AND METHODS
Recombinant LHR-C and LHR-D were used to identify antibodies directed against LHR-C of CR1, into which a point mutation was introduced to characterize the underlying blood group antigens. In addition, database studies to define haplotypes of CR1 were performed.
RESULTS
Several antisera were identified that were specific against CR1 p.1208His and against CR1 p.1208Arg, located in LHR-C. Fifteen KN haplotypes were found in the Ensembl genome browser. It was shown that due to a linkage disequilibrium anti-CR1 p.1208His may be mistaken for anti-KCAM.
CONCLUSION
A novel antithetical KN blood group antigen pair was found at position p.1208 of CR1, for which the names DACY and YCAD are proposed. Antibodies against these two novel antigens seem to contribute to more than a quarter of all KN sera in Europe.

Identifiants

pubmed: 32870515
doi: 10.1111/trf.16039
doi:

Substances chimiques

Antibodies 0
Blood Group Antigens 0
CR1 protein, human 0
Receptors, Complement 3b 0
Recombinant Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2408-2418

Subventions

Organisme : Zentrales Innovationsprogramm Mittelstand (ZIM)
ID : EP170211

Informations de copyright

© 2020 AABB.

Références

Storry JR, Clausen FB, Castilho L, et al. International Society of Blood Transfusion Working Party on red cell immunogenetics and Blood Group Terminology: report of the Dubai, Copenhagen and Toronto meetings. Vox Sang. 2019;114(1):95-102.
Moulds JM, Nickells MW, Moulds JJ, Brown MC, Atkinson JP. The C3b/C4b receptor is recognized by the Knops, McCoy, Swain-Langley, and York blood group antisera. J Exp Med. 1991;173(5):1159-1163.
Klickstein LB, Bartow TJ, Miletic V, Rabson LD, Smith JA, Fearon DT. Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis. J Exp Med. 1988;168(5):1699-1717.
Krych M, Clemenza L, Howdeshell D, Hauhart R, Hourcade D, Atkinson JP. Analysis of the functional domains of complement receptor type 1 (C3b/C4b receptor; CD35) by substitution mutagenesis. J Biol Chem. 1994;269:13273-13278.
Schifferli JA, Ng YC, Estreicher J, et al. The clearance of tetanus toxoid/anti-tetanus toxoid immune complexes from the circulation of humans. Complement- and erythrocyte complement receptor 1-dependent mechanisms. J Immunol. 1988;140(3):899-904.
Moulds JM. The Knops blood-group system: a review. Immunohematology. 2010;26(1):2-7.
Moulds JM, Rowe KE. Neutralization of Knops system antibodies using soluble complement receptor 1. Transfusion. 1996;36(6):517-520.
Moulds JM, Zimmerman PA, Doumbo OK, et al. Molecular identification of Knops blood group polymorphisms found in long homologous region D of complement receptor 1. Blood. 2001;97(9):2879-2885.
Tamasauskas D, Powell V, Schawalder A, Yazdanbakhsh K. Localization of Knops system antigens in the long homologous repeats of complement receptor 1. Transfusion. 2001;41(11):1397-1404.
Scharberg E, Rink G, Portegys J, et al. The impact of using genotyped reagent red blood cells in antibody identification. Transfus Med Hemother. 2018;45:218-224.
Panda AK, Ravindran B, Das BK. CR1 exon variants are associated with lowered CR1 expression and increased susceptibility to SLE in a Plasmodium falciparum endemic population. Lupus Sci Med. 2016;3(1):e000145.
Tamano M, Ohi H, Sudo S, Tomino Y. Quantitative polymorphism of complement receptor type 1 (CR1) in patients undergoing haemodialysis. Nephrol Dial Transplant. 2004;19(6):1467-1473.
Cunningham F, Achuthan P, Akanni W, et al. Ensembl 2019. Nucleic Acids Res. 2019;47(D1):D745-D751.
Moulds JM. The Knops blood group system: a review. Immunohematology. 2010;26(1):2-7.
Hansson HH, Kurtzhals JA, Goka BQ, et al. Human genetic polymorphisms in the Knops blood group are not associated with a protective advantage against Plasmodium falciparum malaria in southern Ghana. Malar J. 2013;12:400.
Auton A, Abecasis G, Altshuler D, et al. A global reference for human genetic variation. Nature. 2015;526:68-74.
Karczewski KJ, Francioli LC, Tiao G, et al. Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes. bioRxiv. 2019;531210.
Crottet SL. Clinical significance of antibodies to antigens in the Scianna, Dombrock, Colton, Landsteiner-Weiner, Chido/Rodgers, H, Kx, Cromer, Gerbich, Knops, Indian, and Ok blood group systems. Immunohematology. 2018;34(3):103-108.

Auteurs

Daniela Grueger (D)

Imusyn GmbH & Co. KG, Hanover, Germany.
Institute of Transfusion Medicine and Transplant Engineering, Hannover Medical School, Hanover, Germany.

Anja Zeretzke (A)

Imusyn GmbH & Co. KG, Hanover, Germany.

Cora P Habicht (CP)

Imusyn GmbH & Co. KG, Hanover, Germany.

Younis Skaik (Y)

Imusyn GmbH & Co. KG, Hanover, Germany.

Franz F Wagner (FF)

German Red Cross Blood Service NSTOB, Springe, Germany.
MVZ am Clementinenkrankenhaus, Springe, Germany.

Erwin A Scharberg (EA)

Institute of Transfusion Medicine and Immunohematology, German Red Cross Blood Service Baden-Württemberg - Hessen, Baden-Baden, Germany.

Aisling Costelloe (A)

RCI Laboratory, National Blood Center, Irish Blood Transfusion Service, Dublin, Ireland.

Jörg Martens (J)

Institute of Transfusion Medicine and Transplant Engineering, Hannover Medical School, Hanover, Germany.

Murielle Verboom (M)

Institute of Transfusion Medicine and Transplant Engineering, Hannover Medical School, Hanover, Germany.

Peter Bugert (P)

Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim, Heidelberg University, German Red Cross Blood Service Baden-Württemberg - Hessen gGmbH, Mannheim, Germany.

Clemens Schneeweiss (C)

Imusyn GmbH & Co. KG, Hanover, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH